{"id":1230,"date":"2022-09-02T16:40:00","date_gmt":"2022-09-02T14:40:00","guid":{"rendered":"http:\/\/mtl.hamstage.hamrenmedia.se\/research-funds-granted-for-participation-in-eucaim-european-cancer-imaging\/"},"modified":"2023-03-28T10:43:48","modified_gmt":"2023-03-28T08:43:48","slug":"forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging","status":"publish","type":"post","link":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/","title":{"rendered":"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging)"},"content":{"rendered":"\n<pre class=\"wp-block-hw-ingress-box\">Ska bidra till infrastruktur p\u00e5 europeisk niv\u00e5. Fredrik Strands forskningsgrupp har som en av deltagarna i projektet EUCAIM (European CAncer IMaging) beviljats EU-anslag p\u00e5 3 miljoner kronor. M\u00e5let med EUCAIM \u00e4r att etablera en europeisk infrastruktur f\u00f6r medicinska cancerbilder.<\/pre>\n\n\n\n<p>Hej Fredrik, vad skulle en s\u00e5dan europeisk infrastruktur inneb\u00e4ra och n\u00e4r skulle den kunna bli verklighet?<br>&nbsp;<br>\u2013 F\u00f6r att utveckla tr\u00e4ffs\u00e4kra maskininl\u00e4rnings-algoritmer beh\u00f6vs mycket data, ofta mer \u00e4n vad som \u00e4r tillg\u00e4ngligt lokalt. N\u00e4r vi dessutom tar sikte p\u00e5 precisionsmedicin, det vill s\u00e4ga att v\u00e4lja behandling mer individuellt utifr\u00e5n cancertum\u00f6rens s\u00e4rskilda egenskaper \u00f6kar behovet \u00e4nnu mer. Internationellt samarbete \u00e4r n\u00f6dv\u00e4ndigt f\u00f6r denna utveckling.<br>&nbsp;<br>Vad kommer ni anv\u00e4nda forskningsmedlen till?<br>&nbsp;<br>\u2013 EU-projektet ligger v\u00e4l i linje med v\u00e5rt p\u00e5g\u00e5ende projekt VAI-B som syftar till att skapa en nationell plattform f\u00f6r utv\u00e4rdering av AI-algoritmer inom br\u00f6stradiologi. Vi hoppas kunna bidra med den kunskap vi samlat p\u00e5 oss tidigare, men ocks\u00e5 med r\u00f6ntgenbilder och kliniska data i en federerad l\u00f6sning p\u00e5 europeisk niv\u00e5.<\/p>\n\n\n\n<p>L\u00e4s mer om utlysningen\u00a0<a href=\"https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/topic-details\/digital-2022-cloud-ai-02-cancer-image\">h\u00e4r<\/a>\u00a0:<br><a href=\"https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/topic-details\/digital-2022-cloud-ai-02-cancer-image\">https:\/\/ec.europa.eu\/info\/funding-tenders\/opportunities\/portal\/screen\/opportunities\/topic-details\/digital-2022-cloud-ai-02-cancer-image<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hej Fredrik, vad skulle en s\u00e5dan europeisk infrastruktur inneb\u00e4ra och n\u00e4r skulle den kunna bli verklighet?&nbsp;\u2013 F\u00f6r att utveckla tr\u00e4ffs\u00e4kra maskininl\u00e4rnings-algoritmer beh\u00f6vs mycket data, ofta mer \u00e4n vad som \u00e4r tillg\u00e4ngligt lokalt. N\u00e4r vi dessutom tar sikte p\u00e5 precisionsmedicin, det vill s\u00e4ga att v\u00e4lja behandling mer individuellt utifr\u00e5n cancertum\u00f6rens s\u00e4rskilda egenskaper \u00f6kar behovet \u00e4nnu mer. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":805,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[57],"tags":[],"class_list":["post-1230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-interviews-sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging) - Medtechlabs<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging) - Medtechlabs\" \/>\n<meta property=\"og:description\" content=\"Hej Fredrik, vad skulle en s\u00e5dan europeisk infrastruktur inneb\u00e4ra och n\u00e4r skulle den kunna bli verklighet?&nbsp;\u2013 F\u00f6r att utveckla tr\u00e4ffs\u00e4kra maskininl\u00e4rnings-algoritmer beh\u00f6vs mycket data, ofta mer \u00e4n vad som \u00e4r tillg\u00e4ngligt lokalt. N\u00e4r vi dessutom tar sikte p\u00e5 precisionsmedicin, det vill s\u00e4ga att v\u00e4lja behandling mer individuellt utifr\u00e5n cancertum\u00f6rens s\u00e4rskilda egenskaper \u00f6kar behovet \u00e4nnu mer. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/\" \/>\n<meta property=\"og:site_name\" content=\"Medtechlabs\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-02T14:40:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-28T08:43:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"hamren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"hamren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/\"},\"author\":{\"name\":\"hamren\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/person\/434303f2fc5cc654e7aae9b6dd7a0610\"},\"headline\":\"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging)\",\"datePublished\":\"2022-09-02T14:40:00+00:00\",\"dateModified\":\"2023-03-28T08:43:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/\"},\"wordCount\":180,\"publisher\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#organization\"},\"image\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg\",\"articleSection\":[\"Intervjuer\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/\",\"url\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/\",\"name\":\"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging) - Medtechlabs\",\"isPartOf\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg\",\"datePublished\":\"2022-09-02T14:40:00+00:00\",\"dateModified\":\"2023-03-28T08:43:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#primaryimage\",\"url\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg\",\"contentUrl\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg\",\"width\":1000,\"height\":650},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#website\",\"url\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/\",\"name\":\"Medtechlabs\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#organization\",\"name\":\"Medtechlabs\",\"url\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/02\/medtechlabs_logo_RGB_orange-65.png\",\"contentUrl\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/02\/medtechlabs_logo_RGB_orange-65.png\",\"width\":480,\"height\":60,\"caption\":\"Medtechlabs\"},\"image\":{\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/person\/434303f2fc5cc654e7aae9b6dd7a0610\",\"name\":\"hamren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7057011de81052044391537cdb2a848061d23579e007d1cf6d51dfc39d69302e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7057011de81052044391537cdb2a848061d23579e007d1cf6d51dfc39d69302e?s=96&d=mm&r=g\",\"caption\":\"hamren\"},\"sameAs\":[\"https:\/\/mtl.hamstage2.hamrenmedia.se\"],\"url\":\"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/author\/hamren\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging) - Medtechlabs","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/","og_locale":"sv_SE","og_type":"article","og_title":"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging) - Medtechlabs","og_description":"Hej Fredrik, vad skulle en s\u00e5dan europeisk infrastruktur inneb\u00e4ra och n\u00e4r skulle den kunna bli verklighet?&nbsp;\u2013 F\u00f6r att utveckla tr\u00e4ffs\u00e4kra maskininl\u00e4rnings-algoritmer beh\u00f6vs mycket data, ofta mer \u00e4n vad som \u00e4r tillg\u00e4ngligt lokalt. N\u00e4r vi dessutom tar sikte p\u00e5 precisionsmedicin, det vill s\u00e4ga att v\u00e4lja behandling mer individuellt utifr\u00e5n cancertum\u00f6rens s\u00e4rskilda egenskaper \u00f6kar behovet \u00e4nnu mer. [&hellip;]","og_url":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/","og_site_name":"Medtechlabs","article_published_time":"2022-09-02T14:40:00+00:00","article_modified_time":"2023-03-28T08:43:48+00:00","og_image":[{"width":1000,"height":650,"url":"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg","type":"image\/jpeg"}],"author":"hamren","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"hamren","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#article","isPartOf":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/"},"author":{"name":"hamren","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/person\/434303f2fc5cc654e7aae9b6dd7a0610"},"headline":"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging)","datePublished":"2022-09-02T14:40:00+00:00","dateModified":"2023-03-28T08:43:48+00:00","mainEntityOfPage":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/"},"wordCount":180,"publisher":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#organization"},"image":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg","articleSection":["Intervjuer"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/","url":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/","name":"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging) - Medtechlabs","isPartOf":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#primaryimage"},"image":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg","datePublished":"2022-09-02T14:40:00+00:00","dateModified":"2023-03-28T08:43:48+00:00","breadcrumb":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#primaryimage","url":"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg","contentUrl":"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/03\/Fredrik_web.jpeg","width":1000,"height":650},{"@type":"BreadcrumbList","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/forskningsmedel-beviljade-for-medverkan-i-eucaim-european-cancer-imaging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/"},{"@type":"ListItem","position":2,"name":"Forskningsmedel beviljade f\u00f6r medverkan i EUCAIM (European CAncer IMaging)"}]},{"@type":"WebSite","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#website","url":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/","name":"Medtechlabs","description":"","publisher":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#organization","name":"Medtechlabs","url":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/logo\/image\/","url":"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/02\/medtechlabs_logo_RGB_orange-65.png","contentUrl":"https:\/\/mtl.hamstage2.hamrenmedia.se\/wp-content\/uploads\/2023\/02\/medtechlabs_logo_RGB_orange-65.png","width":480,"height":60,"caption":"Medtechlabs"},"image":{"@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/person\/434303f2fc5cc654e7aae9b6dd7a0610","name":"hamren","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7057011de81052044391537cdb2a848061d23579e007d1cf6d51dfc39d69302e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7057011de81052044391537cdb2a848061d23579e007d1cf6d51dfc39d69302e?s=96&d=mm&r=g","caption":"hamren"},"sameAs":["https:\/\/mtl.hamstage2.hamrenmedia.se"],"url":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/author\/hamren\/"}]}},"_links":{"self":[{"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/posts\/1230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/comments?post=1230"}],"version-history":[{"count":1,"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/posts\/1230\/revisions"}],"predecessor-version":[{"id":1242,"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/posts\/1230\/revisions\/1242"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/media\/805"}],"wp:attachment":[{"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/media?parent=1230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/categories?post=1230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mtl.hamstage2.hamrenmedia.se\/sv\/wp-json\/wp\/v2\/tags?post=1230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}